Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Director/PDMR Shareholding

23 Mar 2023 15:00

RNS Number : 0580U
Phoenix Group Holdings PLC
23 March 2023
 

Phoenix Group Holdings plc (the "Company")

Exercise of nil-cost options under the Phoenix Group Holdings plc Long Term Incentive Plan (the "LTIP") and Deferred Bonus Share Scheme (the "DBSS").

 

The Company announces that on 22 March 2023, the following Persons Discharging Managerial Responsibilities "PDMRs" exercised their nil-cost options over ordinary shares of £0.10 each in the Company under the LTIP and DBSS granted on 13 March 2020. 

 

LTIP

 

Vesting of these options was subject to criteria relating to the Company's performance over a three-year performance period to 31 December 2022. The options become exercisable for up to 7 years from 13 March 2023.

 

 

Name

Title

Number of ordinary shares acquired of £0.10 each on exercise of options

Claire Hawkins

Corporate Affairs & Investor Relations Director

8432

 

The income tax and national insurance liabilities arising on the exercise of the options were self-funded by Claire Hawkins.

DBSS

 

Vesting of these options was subject to a three-year holding period in respect of the deferred bonus for the 2019 financial year to 31 December 2022. The options become exercisable for up to 6 months with effect from 13 March 2023.

 

Name

Title

Number of ordinary shares acquired of £0.10 each on exercise of options

Claire Hawkins

Corporate Affairs & Investor Relations Director

8407

 

The income tax and national insurance liabilities arising on the exercise of the options were self-funded by Claire Hawkins.

 

 

Notification and public disclosure of transactions by persons discharging managerial

 

The Notification of Dealing Forms for each PDMR can be found below. This announcement is made in accordance with the UK Markets Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018). 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Claire Hawkins

2

 

Reason for the notification

 

a)

 

Position/status

 

Corporate Affairs & Investor Relations Director/PDMR

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Phoenix Group Holdings plc

b)

 

LEI

 

2138001P49OLAEU33T68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Phoenix Group Holdings plc ordinary shares of £0.10

 

 

GB00BGXQNP29

b)

 

Nature of the transaction

 

Exercise of options under the Company's DBSS & LTIP (self-funded tax payment)  

c)

 

Price(s) and volume(s)

 

 

 

Item

Price(s)

Volume(s)

Exercise of LTIP Options

nil

8432

Exercise of DBSS Options

nil

8407

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

N/A

e)

 

Date of the transaction

22 March 2023

f)

Place of the transaction

Outside a trading venue

Enquiries:

Media Douglas Campbell

Teneo

+44 (0)7753 136628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0) 204 559 3031 

Investors Claire Hawkins, Corporate Affairs Director, Phoenix Group+44 (0) 204 559 3161 

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0) 204 559 3145 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZXLFLXXLFBBZ
Date   Source Headline
10th Apr 20249:43 amRNSDirector/PDMR Shareholding
9th Apr 20248:33 amRNSDirector/PDMR Shareholding
8th Apr 20242:15 pmRNSNotice of AGM
3rd Apr 20241:02 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:26 pmRNSTotal Voting Rights
2nd Apr 20244:45 pmRNSDirector/PDMR Shareholding
28th Mar 20245:40 pmRNSDirector/PDMR Shareholding
27th Mar 20244:20 pmRNSAnnual Financial Report
27th Mar 20242:45 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNS2023 Annual Financial Report
6th Mar 20242:00 pmRNSDirector/PDMR Shareholding
1st Mar 20249:35 amRNSTotal Voting Rights
6th Feb 20245:17 pmRNSDirector/PDMR Shareholding
2nd Feb 202410:56 amRNSTotal Voting Rights
1st Feb 20247:00 amRNS2023 Trading Statement
8th Jan 20245:09 pmRNSDirector/PDMR Shareholding
2nd Jan 20243:15 pmRNSTotal Voting Rights
11th Dec 20236:13 pmRNSBlock listing Interim Review
6th Dec 20234:28 pmRNSDirector/PDMR Shareholding
5th Dec 202311:42 amRNSFinal Result of Tender Offer
5th Dec 202310:22 amRNSIndicative Result of Tender Offer
5th Dec 20237:10 amRNSPublication of Final Terms
1st Dec 202311:46 amRNSTotal Voting Rights
28th Nov 20235:46 pmRNSIssue of Debt and Tender Maximum Acceptance Amount
27th Nov 20238:20 amRNSTender Offers and New Issue
24th Nov 202311:05 amRNSDirector Declaration
23rd Nov 20232:00 pmRNSPublication of Supplementary Prospectus
23rd Nov 202310:00 amRNSDirectorate Change
13th Nov 20237:00 amRNSUpgrade of near-term cash generation targets
7th Nov 20235:10 pmRNSDirector/PDMR Shareholding
1st Nov 20232:07 pmRNSDirector/PDMR Shareholding
31st Oct 20232:30 pmRNSHolding(s) in Company
25th Oct 20231:17 pmRNSDirector/PDMR Shareholding
25th Oct 20231:16 pmRNSDirector/PDMR Shareholding
9th Oct 202312:40 pmRNSDirector/PDMR Shareholding
9th Oct 202311:20 amRNSDirector/PDMR Shareholding
4th Oct 202310:00 amRNSBoard Changes
2nd Oct 20233:00 pmRNSPublication of Supplementary Prospectus
2nd Oct 20231:35 pmRNSTotal Voting Rights
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
28th Sep 20232:46 pmRNSDirector/PDMR Shareholding
28th Sep 202312:49 pmRNSAvailability of Interim Financial Report
28th Sep 20237:00 amRNSInterim Financial Report
18th Sep 20237:00 amRNS2023 Interim Results
14th Sep 202310:00 amRNSHY23 reporting update
8th Sep 20239:33 amRNSDirector/PDMR Shareholding
1st Sep 20231:29 pmRNSTotal Voting Rights
9th Aug 20235:04 pmRNSDirector/PDMR Shareholding
1st Aug 20233:16 pmRNSTotal Voting Rights
7th Jul 20233:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.